mozavaptan has been researched along with Auditory Vertigo in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, K; Kakigi, A; Nishimura, M; Okada, T; Takeda, T | 1 |
| Kakigi, A; Nakatani, H; Nishimura, M; Nishioka, R; Okada, T; Taguchi, D; Takeda, S; Takeda, T | 1 |
| Kakigi, A; Nishioka, R; Okada, T; Taguchi, D; Takeda, S; Takeda, T | 1 |
1 review(s) available for mozavaptan and Auditory Vertigo
| Article | Year |
|---|---|
Hormonal aspects of Ménière's disease on the basis of clinical and experimental studies.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzazepines; Diuretics; Ear, Inner; Endolymph; Homeostasis; Humans; Lithium; Meniere Disease; Vasopressins; Water-Electrolyte Imbalance | 2010 |
2 other study(ies) available for mozavaptan and Auditory Vertigo
| Article | Year |
|---|---|
Time course changes of vasopressin-induced enlargement of the rat intrastrial space and the effects of a vasopressin type 2 antagonist.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Endolymphatic Hydrops; Injections, Subcutaneous; Meniere Disease; Microscopy, Electron, Transmission; Premedication; Rats; Stria Vascularis | 2009 |
A comparison of dehydration effects of V2-antagonist (OPC-31260) on the inner ear between systemic and round window applications.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Endolymphatic Hydrops; Guinea Pigs; Humans; Membrane Potentials; Meniere Disease; Microscopy, Electron; Receptors, Vasopressin; Round Window, Ear | 2006 |